Danaher Corporation (DHR) — closed signal from July 23, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on October 21, 2025.
Predicted vs. what happened
What happened
Reached its target in 90 days.
The thesis — published July 23, 2025
Danaher says it will earn more per share in 2025 than it first thought, and its biotech arm is already growing 6 percent, yet the stock is still about 25 percent below its old high. The fall appears overdone, with signs that short-term sellers have run out of steam and fresh buyers are stepping in. With plenty of cash to buy smaller firms and a wave of interest in solid health-science companies, the share price could reasonably rebound toward 225 within three months, offering an appealing near-term opportunity.
Primary drivers
- 2025 profit outlook raised and 6% biotech sales growth tops forecasts.
- Share price looks exhausted after heavy selling; buyers are returning.
- $5B cash war chest lets the firm buy smaller companies and grow faster.
- Money is flowing toward reliable life-science stocks, lifting demand.
How it played out
DHR: target reached in 90 days
Lyra published DHR at 189.31 on 2025-07-23 with an 18% expected gain and a 222.69 target. The thesis pointed to a higher 2025 profit outlook, 6% biotech sales growth, exhausted selling, buyers returning, a $5B cash position for smaller acquisitions, and demand for reliable life-science stocks.
Inside the window, DHR reached a 234.67 peak on 2025-10-21, above the 222.69 target. The target was reached in 90 days. The peak gain was 24%. It ended at 220.46, below the target but still above the publication price. The published thesis played out.
What happened during the window
On October 21, 2025, Danaher reported third-quarter sales of $6.05 billion and adjusted earnings of $1.89 per share, according to Investor's Business Daily.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.